Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors

Gene Therapy

Volumn 9, Issue 10, 2002, Pages 631-641

  Rafii, S ^a   Heissig, B ^a   Hattori, K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adenoviral vectors; Angiogenesis; Hematopoiesis; Metalloproteinases; Mobilization; Tyrosine kinase receptors; Vascular endothelial growth factor; Vasculogenesis

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENIC FACTOR; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; METALLOPROTEINASE; PROTEINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; BLOOD LEVEL; BONE MARROW; CELL PROLIFERATION; CIRCULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; GENE THERAPY; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVASCULARIZATION; REVIEW; STEM CELL; STEM CELL MOBILIZATION; TARGET ORGAN; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; MURINAE;

ADENOVIRIDAE; ADULT; ANIMALS; BONE MARROW CELLS; CELL ADHESION MOLECULES; CELL DIVISION; CELL MOVEMENT; CHEMOKINES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENETIC VECTORS; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOKINES; METALLOENDOPEPTIDASES; MICE; MODELS, ANIMAL; STEM CELL FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036261824     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301723     Document Type: Review

References (127)

1. Stem cells, cancer, and cancer stem cells
2. Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
3. The evolving concept of a stem cell: Entity or function?
4. Bone marrow cells regenerate infarcted myocardium
5. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
6. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
7. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell
8. Stem cell proliferation: Ex vivo and in vivo observations
9. Developmental potential and dynamic behavior of hematopoietic stem cells
10. Purification and characterization of mouse hematopoietic stem cells
11. Mouse hematopoietic stem cells
12. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
13. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells
14. CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors
15. AC133, a novel marker for human hematopoietic stem and progenitor cells
16. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning
17. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice
18. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
19. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices
20. Circulating endothelial precursors: Mystery, reality, and promise
21. Evidence for circulating bone marrow-derived endothelial cells
22. Isolation of putative progenitor endothelial cells for angiogenesis
23. EGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
24. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
25. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
26. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors
27. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells
28. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells
29. The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and peripheral blood
30. Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells
31. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand
32. In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor
33. Modulation of haematopoietic progenitor development by FLT-3 ligand
34. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: Comparison with the effects of FLT3/FLK-2 ligand and interleukin-6
35. Role of c-mpl in early hematopoiesis
36. Thrombopoietin and the hematopoietic stem cell
37. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
38. Hematopoietic deficiencies in c-mpl and TPO knockout mice
39. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: Comparison between FLT3/FLK-2 ligand and KIT ligand
40. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile
41. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone
42. In vitro maintenance of highly purified, transplantable hematopoietic stem cells
43. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo
44. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3 and Kit ligands and RetroNectin culture
45. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains
46. Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: Biologic similarity with membrane-bound form of Steel factor rather than its soluble form
47. Regulation of hematopoiesis by microvascular endothelium
48. Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion
49. Regulation of transendothelial migration of hematopoietic progenitor cells
50. Homing and trafficking of hemopoietic progenitor cells
51. Specificity of hematopoietic stem cell homing
52. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells
53. Lymphocyte homing and homeostasis
54. Adhesion receptors of the immune system
55. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
56. Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin
57. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1
58. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation
59. Transendothelial migration of CD34+ and mature hematopoietic cells: An in vitro study using a human bone marrow endothelial cell line
60. BMEC-1: A human bone marrow microvascular endothelial cell line with primary cell characteristics
61. Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors
62. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: Implications for transendothelial chemotaxis
63. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway
64. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen
65. Molecular basis of homing of intravenously transplanted stem cells to the marrow
66. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood
67. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
68. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
69. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: Stromal cell-derived factor-1, steel factor, and the bone marrow environment
70. Selective secretion of chemoattractants for haemopoietic progenitor cells by bone marrow endothelial cells: A possible role in homing of haemopoietic progenitor cells to bone marrow
71. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment
72. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
73. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: Their functions in development, hematopoiesis and HIV infection
74. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
75. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
76. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines
77. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1
78. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution
79. Marrow engraftment of hematopoietic stem and progenitor cells is independent of Galphai-coupled chemokine receptors
80. Vascular endothelial growth factor is a secreted angiogenic mitogen
81. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo
82. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
83. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
84. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor
85. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration
86. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14
87. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform
88. Genomic organization of human and mouse genes for vascular endothelial growth factor C
89. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B and VEGF-C messenger ribonucleic acid levels in cultured human granulosaluteal cells
90. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7, VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
91. Vascular endothelial growth factor (VEGF) and its receptors
92. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
93. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
94. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells
95. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
96. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype
97. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
98. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit
99. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
100. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
101. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (P1GF) in regulating human haemopoietic cell growth
102. KDR receptor: A key marker defining hematopoietic stem cells
103. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells
104. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
105. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
106. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
107. Angiopoietin-1 induces sprouting angiogenesis in vitro
108. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
109. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
110. In vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine aorta-gonad-mesonephros region
111. In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells
112. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
113. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
114. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo
115. Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts
116. Blood-borne seeding by hematopoietic and endothelial precursors from the allantois
117. Chemokines
118. Chemokines - Chemotactic cytokines that mediate inflammation
119. High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors
120. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
121. Immunologic barriers to hepatic adenoviral gene therapy for transplantation
122. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants
123. Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: Insights into the pathophysiology of osteomyelofibrosis
124. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression
125. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells
126. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells
127. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells